Application of phage display technology in targeted therapy of breast cancer

Article
First Online:
Received:
Revised:
Accepted:

Abstract

Phage display is a technology of gene expression and screening, it is widely used in the fields of defining antigen epitopes, signal transduction, genetic treatment, parasites research and tumor targeted therapy. Breast cancer is the most common cancer in women, we can obtain peptides specially associated with breast cancer by using phage display technology, and this method has great potential in early diagnosis of breast cancer and development new targeted drugs.

Key words

phage display phage peptide library peptides breast neoplasms targeted therapy 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin, 2011, 61: 69–90.PubMedCrossRefGoogle Scholar
  2. 2.
    Smith GP. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science, 1985, 228: 1315–1317.PubMedCrossRefGoogle Scholar
  3. 3.
    Li Q, Gao S, Yu Y, et al. A novel bFGF antagonist peptide inhibits breast cancer cell growth. Mol Med Rep, 2012, 6: 210–214.PubMedGoogle Scholar
  4. 4.
    Park HY, Lee KJ, Lee SJ, et al. Screening of peptides bound to breast cancer stem cell specific surface marker CD44 by phage display. Mol Biotechnol, 2012, 51: 212–220.PubMedCrossRefGoogle Scholar
  5. 5.
    Zhong L, Ge K, Zu JC, et al. Autoantibodies as potential biomarkers for breast cancer. Breast Cancer Res, 2008, 10: R40.PubMedCrossRefGoogle Scholar
  6. 6.
    Zhao W, Meng L, Gao YJ, et al. Screening of breast cancer antigen from a phage display random peptide library. Chin J Cell Mol Immunol (Chinese), 2010, 26: 951–954.Google Scholar
  7. 7.
    Wang J, Wang H, Wang C, et al. Isolation and identification of single chain Fv antibodies against breast cancer from a human phage display library. Chin J Cell Mol Immunol (Chinese), 2012, 28: 837–840.Google Scholar
  8. 8.
    Wiiger MT, Gehrken HB, Fodstad Ø, et al. A novel human recombinant single-chain antibody targeting CD166/ALCAM inhibits cancer cell invasion in vitro and in vivo tumour growth. Cancer Immunol Immunother, 2010, 59: 1665–1674.PubMedCrossRefGoogle Scholar
  9. 9.
    Dong J, Liu WQ, Jiang AM, et al. A novel peptide, selected from phage display library of random peptides, can efficiently target into human breast cancer cell. Chin Sci Bull, 2008, 53: 860–867.CrossRefGoogle Scholar
  10. 10.
    Chen LS, Wang AX, Dong B, et al. A new prospect in cancer therapy: targeting cancer stem cells to eradicate cancer. Chin J Cancer, 2012, 31: 564–572.PubMedCrossRefGoogle Scholar
  11. 11.
    Gur D, Liu S, Shukla A, et al. Identification of single chain antibodies to breast cancer stem cells using phage display. Biotechnol Prog, 2009, 25: 1780–1787.PubMedGoogle Scholar
  12. 12.
    Li Z, Liu CP, He YL, et al. The expression and significance of multidrug resistance genes in breast cancer stem cells. Chinese-German J Clin Oncol, 2008, 7: 538–541.CrossRefGoogle Scholar
  13. 13.
    Li XB, Schluesener HJ, Xu SQ. Molecular addresses of tumors: selection by in vivo phage display. Arch Immunol Ther Exp (Warsz), 2006, 54: 177–181.CrossRefGoogle Scholar
  14. 14.
    Pasqualini R, Ruoslahti E. Organ targeting in vivo using phage display peptide libraries. Nature, 1996, 380: 364–366.PubMedCrossRefGoogle Scholar
  15. 15.
    Arap W, Pasqualini R, Ruoslahti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science, 1998, 279: 377–380.PubMedCrossRefGoogle Scholar
  16. 16.
    Essler M, Ruoslahti E. Molecular specialization of breast vasculature: a breast-homing phage-displayed peptide binds to aminopeptidase P in breast vasculature. Proc Natl Acad Sci USA, 2002, 99: 2252–2257.PubMedCrossRefGoogle Scholar
  17. 17.
    Zhang WJ, Liu XR, Li GC, et al. Construction and selection of human Fab antibody phage display library of extracellular domain of HER2. Chin J Cell Mol Immunol (Chinese), 2011, 27: 297–300.Google Scholar
  18. 18.
    Liu X, He Z, Zhou M, et al. Purification and characterization of recombinant extracellular domain of human HER2 from Escherichia coli. Protein Expr Purif, 2007, 53: 247–254.PubMedCrossRefGoogle Scholar
  19. 19.
    Jiang B, Liu W, Qu H, et al. A novel peptide isolated from a phage display peptide library with trastuzumab can mimic antigen epitope of HER-2. J Biol Chem, 2005, 280: 4656–4662.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  1. 1.State Key Laboratory of Oncology in Southern ChinaGuangzhouChina
  2. 2.Department of Breast SurgeryThe Central Hospital of TaianTaianChina
  3. 3.Department of Thoracic SurgerySun Yat-sen University Cancer CenterGuangzhouChina

Personalised recommendations